Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug;35(8):2398-2405.
doi: 10.1007/s11606-020-05836-9. Epub 2020 May 14.

Medication to Manage Abortion and Miscarriage

Jessica Beaman  1 , Christine Prifti  2 , Eleanor Bimla Schwarz  3 , Mindy Sobota  4
Affiliations
Review

Medication to Manage Abortion and Miscarriage

Jessica Beaman et al. J Gen Intern Med. 2020 Aug.

Abstract

Abortion and miscarriage are common, affecting millions of US women each year. By age 45, one in four women in the USA will have had an abortion, and at least as many will have had a miscarriage. Most individuals seeking abortion services do so before 10 weeks' gestation when medication abortions are a safe and effective option, using a regimen of oral mifepristone followed by misoprostol tablets. When a pregnancy is non-viable before 13 weeks' gestation, it is referred to as an early pregnancy loss or miscarriage and can be managed using the same mifepristone and misoprostol regimen. Given their safety and efficacy, mifepristone and misoprostol can be offered in ambulatory settings without special equipment or on-site emergency services. As more patients find it difficult to access clinical care when faced with an undesired pregnancy or a miscarriage, it is important for general internists and primary care providers to become familiar with how to use medications to manage these common conditions. We summarize the most recent evidence regarding the use of mifepristone with misoprostol for early abortion and miscarriage. We discuss clinical considerations and resources for integrating mifepristone and misoprostol into clinical practice. By learning to prescribe mifepristone and misoprostol, clinicians can expand access to time-sensitive health services for vulnerable populations.

Keywords: family planning; medication abortion; miscarriage; primary care; women’s health.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they do not have a conflict of interest.

Figures

Figure 1
Figure 1
Combining mifepristone and misoprostol to treat undesired pregnancy or miscarriage. hCG, human chorionic gonadotropin
See this image and copyright information in PMC

Comment in

References

    1. Daniel H, Erickson SM, Bornstein SS. Women’s health policy in the United States: an American College of Physicians position paper. Ann Intern Med. 2018;168(12):874–5. - PubMed
    1. Curtin SC, Abma JC, Kost K. Pregnancy rates among U.S. women. 2010. Available at: https://www.cdc.gov/nchs/data/hestat/pregnancy/2010_pregnancy_rates.htm#... 1. Accessed July 3, 2019.
    1. Jones RK, Jerman J. Population group abortion rates and lifetime incidence of abortion: United States, 2008-2014. Am J Public Health. 2017;107(12):1904–9. - PMC - PubMed
    1. The American College of Obstetricians and Gynecologists. Early pregnancy loss. Available at: https://www.acog.org/Patients/FAQs/Early-Pregnancy-Loss?IsMobileSet=false. Accessed July 3, 2019.
    1. Jatlaoui TC, Eckhaus L, Mandel MG, et al. Abortion Surveillance – United States, 2016. MMWR Surveill Summ. 2019;68(11):1–41. - PubMed